Binding of plasmin (ogen) to rat C6 glioma cells is saturable and kringle-domain dependent. This interaction was studied as a model of plasimin(ogen) receptor interactions in nucleated mammalian cells. Apparent l25 I-plasmin dissociation from OS cell binding sites was slow; however, the dissociation rate was increased when the solution contained diisopropyl phosphoryl-plasmin (0.3 juM), fibrinogen (0.16 or 0.8 mg/ml), 1.08 mM D-Val-L-Leu-L-Lys-p-nitroanilide-HCl (S-2251), or e-amino-n-caproic acid (EACA, 5.0 mM). EACA promoted the most rapid dissociation of plasmin. C6 cell-associated plasmin and plasmin in solution demonstrated similar amidase activity. Only specifically bound plasmin (75% of total binding) was active against S-2251. Plasmin that was initially bound to C6 cells digested fibrinogen in a time-and plasmin concentration-dependent manner. o^-Antiplasmin (<* 2 AP, 0.1 fiM) completely inhibited fibrinogenolysis by plasmin that was initially C6 • or human umbilical vein endothelial-cell associated. Since a 2 AP reacts selectively with plasmin in solution (minimally with plasmin bound to cells), fibrinogen digestion by cell-associated plasmin probably occurred only after the plasmin dissociated into solution. Crosslinked fibrin clots were formed in uniform layers over C6 cells. If the cells were incubated with plasmin before addition of fibrinogen and thrombin, the clots were rapidly lysed. <x 2 AP incompletely inhibited fibrinolysis when added after fibrin polymerization (44% inhibition with 0
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Binding of plasmin (ogen) to rat C6 glioma cells is saturable and kringle-domain dependent. This interaction was studied as a model of plasimin(ogen) receptor interactions in nucleated mammalian cells. Apparent l25 I-plasmin dissociation from OS cell binding sites was slow; however, the dissociation rate was increased when the solution contained diisopropyl phosphoryl-plasmin (0.3 juM), fibrinogen (0.16 or 0.8 mg/ml), 1.08 mM D-Val-L-Leu-L-Lys-p-nitroanilide-HCl (S-2251), or e-amino-n-caproic acid (EACA, 5.0 mM). EACA promoted the most rapid dissociation of plasmin. C6 cell-associated plasmin and plasmin in solution demonstrated similar amidase activity. Only specifically bound plasmin (75% of total binding) was active against S-2251. Plasmin that was initially bound to C6 cells digested fibrinogen in a time-and plasmin concentration-dependent manner. o^-Antiplasmin (<* 2 AP, 0.1 fiM) completely inhibited fibrinogenolysis by plasmin that was initially C6 • or human umbilical vein endothelial-cell associated. Since a 2 AP reacts selectively with plasmin in solution (minimally with plasmin bound to cells), fibrinogen digestion by cell-associated plasmin probably occurred only after the plasmin dissociated into solution. Crosslinked fibrin clots were formed in uniform layers over C6 cells. If the cells were incubated with plasmin before addition of fibrinogen and thrombin, the clots were rapidly lysed. <x 2 AP incompletely inhibited fibrinolysis when added after fibrin polymerization (44% inhibition with 0.1 /tM or 2 AP). Fibrinolysis was completely inhibited when t^AP was added before fibrin polymerization. These studies suggest that plasmin must first dissociate from cellular binding sites to mediate fibrinogenolysis or fibrinolysis. After dissociation, plasmin activity is modulated by antiplasmins, which are ineffective at the cell surface. is well characterized; however, plasmin has many other physiologically significant substrates, including metalloproteinase zymogens, extracellular matrix proteins, and cytokines. 12 The complete structure of [Glu']-plasminogen includes 791 amino acids and either one or two oligosaccharide chains. 3 -6 Part of the plasmin(ogen) sequence forms five homologous kringle domains, each with about 80 amino acids. ' The kringle domains contain lysine-binding sites, which allow plasmin(ogen) to associate noncovalently with diverse macromolecules. 7 -11 Kringle-mediated interactions promote substrate cleavage, increase plasminogen activation, 11 -13 and protect plasmin from the rapidly acting antiplasmins, a 2 -antiplasmin (a 2 AP) and a 2 -macroglobulin (a 2 M).
10^15
Most nucleated cells bind plasminogen and plasmin with similar affinity (K D 0.3-3.0 /uM). 11 There is some variability in the number of binding sites per cell; however, in general, the number is high (10 5 -10 7 per cell). The biochemical nature of the cellular plasminogen) binding sites remains incompletely understood. Different membrane-associated macromolecules may bind plasmin(ogen) with comparable affinity, affecting the activity of plasmin similarly.
1011 Since more than one plasmin(ogen) domain may be involved in cellular receptor interactions, the possibility of cooperativity in binding cannot be excluded.
1516
Plasmin that is activated on the cell surface dissociates relatively slowly. 15 Therefore, plasmin may demonstrate significant activity toward various substrates while bound to cells. One physiologically significant substrate for cell-associated plasmin is high-molecular-weight single-chain urokinase (scu-PA).
1317 Scu-PA, which is bound to urokinase plasminogen activator receptor (uPAR), is converted into the active two-chain enzyme at the cell surface. Cell-associated plasmin also cleaves small chromogenic and fluorogenic substrates. 18 
Methods

Reagents
Earle's balanced salt solution (EBSS), minimum essential medium with EBSS (MEM), and bovine crystalline insulin were from GIBCO Laboratories, St. Lawrence, Mass. Fetal calf serum, p-nitrophenyl p'-guanidinobenzoate hydrochloride (PNPGB), bovine serum albumin (BSA, 98-99% pure, fatty acid free), bovine thrombin, and diisopropylphosphorofluoridate were from Sigma Chemical Co., St. Louis, Mo. Fibrinogen and D-Val-L-Leu-L-Lys-p-nitroanilide-HCl (S-2251) were from KabiVitrum AB, Stockholm, Sweden. Na 125 I was from Amersham, Arlington Heights, 111., and Iodobeads were from Pierce Chemical, Rockford, 111. Low-molecular-weight urokinase (u-PA) was from Calbiochem Corporation, La Jolla, Calif. Spli-Prest kits for determining fibrin(ogen) digestion products were from Diagnostica Stago, Asniere-Sur-Seine, France.
Proteins
[Glu']-plasminogen was purified from human plasma as previously described. 19 Each preparation included a mixture of carbohydrate variants I and II (60-70% type II). 24 Plasminogen (100-200 fig) was activated with 50 units of u-PA for 15 minutes at 37°C. Streptokinase was purified from Kabikinase (KabiVitrum) by the method of Castellino et al. 25 Fibrinogen was depleted of plasminogen by chromatography on lysine-Sepharose. Complete removal of plasminogen was verified by measuring S-2251 hydrolysis after addition of streptokinase. « 2 AP was purified by the method of Wiman 26 and a 2 M by the method of Imber and Pizzo. 27 
Radioiodination
Fibrinogen, plasminogen, and a 2 AP were radioiodinated with Iodobeads. Specific activities of 125 Ifibrinogen, I-Plasminogen was activated with u-PA as described above.
125
I-Plasmin activity was decreased by less than 5% compared with nonradiolabeled enzyme, as determined by S-2251 hydrolysis. By sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), 125 I-plasminogen activation resulted in complete conversion of the single-chain zymogen into the two-chain active-enzyme form.
Cell Culture
Rat C6 glioma cells were obtained from American Tissue Type Collection (ATCC), Rockville, Md., and cultured in MEM with 10% fetal calf serum as previously described. 22 Experiments were performed using 90-95% confluent monolayers in 24-well cell-culture plates (GIBCO). HUVECs were also obtained from ATCC and cultured as previously described. 28 Plasmin Binding Experiments l25 I-Plasmin was incubated with C6 glioma cells in EBSS with 10 mM N-hydroxyethylpiperazine-JV'-aethanesulfonic acid (HEPES) and 10 mg/ml BSA, pH 7.4 (EHB buffer), for 2 hours at 4°C. e-Amino-n-caproic acid (EACA) (5.0 mM) was included in some wells. EACA inhibits plasminogen binding to cells by interacting with the ligand (instead of the receptor); specific binding is equivalent when determined with EACA or a 50-fold molar excess of nonradiolabeled plasminogen. 19 - 29 After washing the cells three times, cell-associated radioactivity was recovered in 0.1 M NaOH and 2% SDS. Cellular protein was determined by the method of Lowry, as reviewed by Peterson. 30 Plasmin, at concentrations up to 0.1 fiM, had no effect on the integrity of the cell layers, as determined by cell counts of the supernatants and phase-contrast microscopy, or on cellular viability as determined by trypan blue exclusion.
Plasmin Dissociation Experiments
Cultures of C6 glioma cells were incubated with 0.1 HM 
Fibrinogenolysis
C6 cells were incubated with plasmin for 2 hours at 4°C. The monolayers were washed and then incubated with fibrinogen (250 /AI, 0.16 mg/ml) at 22°C. At various times, solutions were recovered, treated with the immediate plasmin inhibitor PNPGB (0.1 mM), denatured in 1.0% SDS, and subjected to SDS-PAGE on 6% slabs. Fragments X, Y, and D were identified by comparison with molecular-weight standards (BioRad).
A more quantitative method to monitor fibrinogenolysis was as follows. Washed cultures of C6 cells with bound plasmin were incubated with 
Fibrinogenolysis in the Presence of Antiplasmins
Fibrinogen and a 2 AP or a 2 M were added simultaneously to cultures of C6 cells with bound plasmin. Fibrinogenolysis was then analyzed by SDS-PAGE or by 125 I-fibrinogen incorporation into clots as described above. Identical experiments were performed with HUVEC cultures.
Fibrinolysis by Cell-Associated Plasmin
Plasmin was incubated with C6 cells for 2 hours at 4°C. After washing the monolayers, 150 p,l of 1Zi Ifibrinogen (2 mg/ml) was added immediately, followed by addition of thrombin (2 NIH units). A visible clot formed within 5 minutes at 22°C. EBSS and 10 mM HEPES, pH 7.4 (150 /AI), was slowly added on top of each formed clot. Incubation was then continued for up to 2 hours at 22°C. At various times, additional buffer (200 jul) was added to each well, and the fibrin clots were carefully removed with wooden applicator sticks. The radioactivity present in the wells after removing the clots was determined.
Fibrinolysis in the Presence of a 2 AP
Fibrinolysis experiments were performed in the presence of « 2 AP (0.01-1.0 /xM). The a 2 AP was added either with the 125 I-fibrinogen before forming the clot or in the 150 id added gently above the clots 5 minutes after the thrombin was added.
Crosslinking of a 2 AP Into Fibrin Clots
The fibrin clots that formed above C6 cell cultures were analyzed by SDS-PAGE under reducing conditions to study a-and y-chain crosslinking. The fibrin clots were solubilized in 2.0 M urea, 1.0% SDS, and 3 mg/ml dithiothreitol for 12 hours at 22°C. SDS-PAGE was performed on 8.0% slabs. In some experiments, 125 I-a 2 AP was included with the fibrinogen before addition of thrombin. Covalent binding of a 2 AP to the clot, which is a function of factor XHIa activity, was judged by the appearance of a band with an apparent M, of 120,000 by autoradiography. To quantify the amount of 125 I-a 2 AP in this band, gels were sliced into 3-mm sections, and each section was counted in a gamma counter.
Results
Plasmin Binding to C6 Cells
The binding of DIP-plasmin to C6 cells has been studied previously. 15 The K D and B max were 0.9 /xM and 2.6xlO 6 
Plasmin Dissociation From C6 Cells
The apparent dissociation of 125 I-plasmin from C6 cell binding sites into buffered EBSS at 22°C was relatively slow (Figure 1 ). BSA at concentrations up to 10 mg/ml did not affect the rate of 125 I-plasmin dissociation. Therefore, plasmin dissociation experiments were performed in a standard manner with EHB buffer, which contains BSA. When DIP-plasmin (0.3 fiM) was included in the medium to prevent 125 I-plasmin reassociation, the radioligand accumulated in solution somewhat more rapidly (30% dissociation in 15 minutes). A further increase in apparent plasmin dissociation was not observed when the concentration of DIP-plasmin was increased to 1.0 /iM.
A small increase in apparent 125 I-plasmin dissociation rate was observed when fibrinogen (0.16 mg/ml) was included in solution; 31% of the plasmin was recovered in solution after incubation for 15 minutes. Comparable data were obtained with 0.8 mg/ml fibrinogen (35% dissociation in 15 minutes; complete study not shown). The increase in apparent 125 I-plasmin dissociation rate caused by fibrinogen probably reflects the ability of fibrinogen to bind dissociated plasmin and prevent reassociation. A slight increase in apparent 125 I-plasmin dissociation was also observed with 1.08 mM S-2251 (compared with EHB buffer). When DIP-plasmin was present, S-2251 did not further increase the apparent rate of plasmin dissociation (data not shown).
While it is well documented that EACA and other lysine analogues inhibit specific binding of plasminogen) to cell surfaces, 111929 the effect of EACA on plasmin dissociation rate has not been fully characterized. The apparent rate of 125 I-plasmin dissociation was markedly increased by EACA ( Figure 1) ; more than 50% of the plasmin was recovered in solution by 2.5 minutes. The dissociation curve in the presence of EACA was not monophasic; approximately 30% of the 
Plasmin Amidase Activity
To compare the amidase activities of specifically and nonspecifically bound plasmin, C6 cells were incubated with plasmin in the presence or absence of EACA. After washing the cultures to remove unbound plasmin, S-2251 hydrolysis was examined (Figure 2 ). Within the S-2251 concentration range studied (0.09-0.54 mM), amidase activity was a property of specifically bound plasmin only.
We demonstrated that 5.0 mM EACA does not affect the hydrolysis of S-2251 by plasmin in solution (see "Methods"). This allowed us to exploit the ability of EACA to rapidly dissociate specifically bound plasmin to compare the amidase activities of identical amounts of free and cell-associated plasmin. C6 cells with bound plasmin were incubated with S-2251 or with S-2251 and 5.0 mM EACA at 22°C (Figure 3 ). When plasmin dissociation was promoted with EACA, the amidase activity was slightly increased or unchanged compared with wells that did not receive EACA. These studies indicate that the amidase activities of free and C6 cell-associated plasmin are similar. It should be noted that when the S-2251 concentration was low, substrate consumption may have affected the apparent amidase activity after the first 3-5 minutes.
We have previously demonstrated that the amidase activity of C6 cell-associated plasmin is at least partially resistant to inhibition by a 2 AP. 24 In the present investigation, we confirmed these results. C6 cells were incubated with 0.1 juM plasmin, washed, and then incubated with S-2251 and a 2 AP simultaneously for 30 minutes. Activities were compared with those observed when only S-2251 (no a 2 AP) was added. Table 1 shows that cell-associated plasmin retained significant activity in the presence of concentrations of a 2 AP that completely inactivated a comparable amount of plasmin in solution. When incubations with S-2251 and a 2 AP were conducted for less than 30 minutes, the calculated percentages of retained activity were higher (data not shown). This result was expected, since plasmin slowly but I-fibrinogen was incubated with a comparable amount of plasmin in solution (4.0 nM) for 30 minutes, 83±5% digestion was observed. Therefore, fibrinogenolysis was more rapid when the plasmin was in solution compared with plasmin that was initially cell associated.
To determine whether plasmin expresses fibrinogenolytic activity while bound to C6 cells and thus protected from rapid antiplasmins, 125 I-fibrinogen digestion was studied in the presence of a 2 AP. Fibrinogeno- Plasmin that was bound to C6 cells or a comparable amount of plasmin in solution was incubated with 0.54 mM S-2251 and the specified concentrations of a 2 -antiplasmin (a 2 AP) for 30 minutes. Absorbance at 405 nm was then determined. Activity in the presence of a 2 AP is expressed as a percentage of that observed in the absence of a 2 AP.
lysis by cell-associated plasmin was completely inhibited by 0.1 fiM a 2 AP (Table 2 ). Fibrinogen digestion was inhibited 86% by 10 nM a 2 AP; equivalent inhibition was observed when fibrinogen and 10 nM a 2 AP were incubated with plasmin in solution. These results were confirmed by SDS-PAGE. a 2 M also inhibited fibrinogenolysis whether the plasmin was initially free in solution or cell associated ( Table 2 ). The slight difference in the ability of 10 nM a 2 M to inhibit the plasmin that was initially bound to cells compared with free plasmin was not statistically significant. These experiments strongly suggest that the digestion of fibrinogen caused by C6 cell-associated plasmin is primarily a function of the plasmin that gradually dissociates from cellular binding sites. Plasmin that is bound to the cell membrane and is thus protected from a 2 AP or a 2 M does not digest significant levels of fibrinogen. When fibrinogen digestion experiments were performed with HUVEC cultures instead of C6 cells, equivalent results were obtained; fibrinogenolysis mediated by HUVEC-associated plasmin was completely inhibited by solution-phase proteinase inhibitors, indicating the requirement for plasmin dissociation (data not shown).
Fibrinolysis by Cell-Associated Plasmin
Fibrinogen above C6 cell monolayers clotted when thrombin was added, forming uniform translucent layers. 10 From measurements of visible light diffraction, fibrin polymerization was complete within 5 minutes. A small gap (<0.05 mm) typically formed between the fibrin clot and the walls of the tissue-culture well as determined by examination with a x 15 dissecting microscope. Analysis of the fibrin clots by SDS-PAGE showed almost complete loss of the y-chain monomer band and a prominent -y-chain dimer band within 5 minutes. Some a-chain polymers were also evident (data not shown). Therefore, the fibrin in solution above C6 cells polymerized and was crosslinked by factor XHIa (an expected component of the fibrinogen preparation).
When C6 cells were not preincubated with plasmin, the fibrin clots were stable for up to 2 hours (after which monitoring was discontinued). Cells that were preincubated with 0.05 /xM plasmin degraded 16.3 ±0.6% of the fibrin clot within 1 hour (determined by the radioactivity released from the clot); 39 ±6% of the clot was digested within 2 hours. Initially, the ability of a 2 AP to inhibit fibrin clot digestion by cell-associated plasmin was studied by adding a 2 AP after the fibrin clot had formed ( Figure 5 ). When 0.01 juM a 2 AP was added, the amount of a 2 AP exceeded the total level of available plasmin by about a factor of three; however, significant inhibition of fibrinolysis was not observed. Fibrin clot lysis was partially inhibited by 0.1 or 1.0 /xM a 2 AP; however, inhibition was still incomplete. The incomplete effectiveness of a 2 AP in this system is best explained by the idea that the fibrin clot acts as a physical barrier that separates plasmin from solution-phase a 2 AP. This barrier permits the partial digestion of the clot either by cell-associated plasmin or by plasmin that is transferred from the cell surface to the clot in an inhibitor-free microenvironment.
When 125 I-« 2 AP (0.1 /xM) was added to the cell culture wells with the fibrinogen before thrombin was added, 17.2% of the a 2 AP was covalently incorporated into the clot as determined by SDS-PAGE, autoradiography, and gel slicing. After incubation with 10 nM l-a 2 AP, 25.1% incorporation was demonstrated. The addition of « 2 AP before fibrin clot formation greatly increased the effectiveness of « 2 AP as an inhibitor of clot lysis. Only 7.2% of maximum lysis was achieved in the presence of 1.0 /AM a 2 AP; 10.4% of maximum lysis was achieved with 0.1 /AM a 2 AP. Based on a Student's paired t test, these percentages were not statistically different from complete inhibition of fibrinolysis (no plasmin present) at the/?=0.05 level.
Discussion
Cell-associated plasmin(ogen) and uPAR-associated high-molecular-weight u-PA interact to strongly promote plasminogen activation.
-
17
- 20 Cell-associated plasmin effectively converts scu-PA into the more active two-chain form. 13 ' 17 Both forms of u-PA (scu-PA and two-chain u-PA) activate plasminogen with increased catalytic efficiency at the cell surface.
20
- 31 In addition, some cell types promote the activation of plasminogen by tissue-type plasminogen activator.
19
- 29 As a result of these reactions, substantial levels of cell-associated plasmin may be generated. Apart from scu-PA, physiologically significant substrates for cell-associated plasmin remain to be defined.
The studies presented here and elsewhere 15 demonstrate that plasmin dissociates from cellular binding sites relatively slowly. Therefore, it is possible that plasmin, while bound to cell membranes, cleaves physiologically significant substrates other than scu-PA. In this investigation, we have demonstrated that plasmin that is bound to C6 cells retains substantial catalytic efficiency against a small chromogenic substrate. Nevertheless, the activity of C6 cell-or HUVEC-associated plasmin toward fibrinogen in a "dissociation-controlled" experimental system (a 2 AP or a 2 M presenr.) is essentially undetectable.
The choice of C6 cells as a model system for plasminogen receptors is based on extensive comparisons with other cell types, including endothelial cells and hepatocytes.
-
22
- 24 In previous studies of plasminogen binding affinity, capacity, dissociation rate constant, and reactivity of bound plasmin with proteinase inhibitors, C6 cells have behaved equivalently to these other cell types. The greatly decreased activity of plasmin toward fibrinogen when the former is bound to C6 cells or HUVECs represents another equivalence that is demonstrated here.
Every large solution-phase plasmin substrate studied thus far reacts minimally with plasmin that is bound to cell surfaces. The inhibition of plasmin by a 2 AP, which mechanistically is initiated as an enzyme-substrate interaction, occurs at a rate that is decreased dramatically when the plasmin is cell associated.' 5 -20 This decrease might reflect occupancy of the plasmin kringle domains by cell-surface macromolecules and/or steric constraints imposed by the plasma membrane. The complete or nearly complete inability of a 2 M to react with cellassociated plasmin probably represents entirely steric constraints. 15 Fibrinogen digestion by cell-associated plasmin is probably restricted by steric constraints and/or occupancy of the kringle domains by cell surface macromolecules. Therefore, when plasmin is generated on the surfaces of cells that are exposed to blood, the fibrinogen within the plasma will not be compromised so long as a 2 AP or a 2 M is present.
The ability of EACA to promote plasmin dissociation from cellular binding sites supports the hypothesis that this interaction is mediated by multiple plasmin kringle domains, as proposed by Miles et al. 16 Each cellassociated plasmin molecule may be viewed as having multiple kringles reversibly engaging and disengaging membrane binding sites. For plasmin dissociation to occur, all of the kringle domains must be disengaged simultaneously. We hypothesize that EACA promotes plasmin dissociation by binding to individual kringle domains as these domains disengage from membrane sites. This interaction then prevents the individual kringle from rebinding to the cell surface.
Under normal conditions, endothelial cells and other cells that are exposed to blood express a variety of macromolecules that inhibit thrombosis. 32 For this reason, blood clot formation is usually limited to denuded blood vessel walls. Whether plasmin that is formed on intact cell surfaces adjacent to areas of thrombosis can digest and thereby restrict the extension of the clot is an important question that is partially addressed in the present study. The lysis of fibrin clots formed above cells in culture occurred only when a 2 AP was excluded during fibrin polymerization. These results suggest that a 2 AP, which is incorporated into fibrin, represents a major impediment to clot digestion whether the plasmin is derived from solution or the cell surface. Based on the ability of the fibrin clot to form a barrier between cell-associated plasmin and proteinase inhibitors in solution, we can speculate that fibrinolysis will be promoted from the cellular side once the fibrin-associated a 2 AP is overcome. The major limitation in determining the importance of cell surface-derived plasmin in the lysis of fibrin clots is the inability to predict how much cell-associated plasmin is generated under various conditions. If sufficient plasmin can be generated to overcome clot-associated a 2 AP, then lysis can occur from the cell surface, perhaps until communication with the vascular compartment is reestablished.
The exclusion of large soluble proteins from interaction with cell-associated plasmin is not complete, since plasmin-specific anticatalytic antibodies bind receptorbound plasmin. 17 It is possible, however, that the primary substrates of cell-associated plasmin are not related to hemostasis. Other potential candidate substrates include cytokines, extracellular matrix proteins, cellular receptors, and the zymogen forms of other enzymes.
